The global PEGylated proteins market is anticipated to grow at a considerable CAGR of 1.8% during the forecast period 2023-2030. The rising FDA approvals to increase therapeutic application of PEGylated proteins is a key factor driving the growth of the global PEGylated proteins market. For instance, in December 2022, Protalix BioTherapeutics, Inc., a biopharmaceutical company focused...

The global PEGylated proteins market is anticipated to grow at a considerable CAGR of 1.8% during the forecast period 2023-2030). The rising FDA approvals to increase therapeutic application of PEGylated proteins are a key factor driving the growth of the global PEGylated proteins market. For instance, in December 2022, Protalix BioTherapeutics, Inc., a biopharmaceutical company...